Mark Jalkut

Neoadjuvant Clinical Trial With Sorafenib for Patients With Stage II or Higher Renal Cell Carcinoma

C. Lance Cowey, Chirag Amin, Raj S. Pruthi et al. · Journal of Clinical Oncology · 2010 · 197 citations · Full text

IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer

Karim Chamie, Sam S. Chang, Eugene V. Kramolowsky et al. · NEJM Evidence · 2022 · 136 citations

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center

Stephen J. Freedland, Mark Jalkut, Frederick J. Dorey et al. · Urology · 2000 · 77 citations

Urology, Biochemical Recurrence, Genitourinary Cancer +8

Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men

Robert L. Waterhouse, Leander Van Neste, Kelvin A. Moses et al. · Urology · 2018 · 38 citations · Full text

The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Steven A. Kaplan, Jared Moss, Sheldon Freedman et al. · The Journal of Urology · 2023 · 35 citations · Full text